An intriguing finding was that resveratrol treatment in women with severe obesity increased insulin action and AMPK phosphorylation without changing other components in the AMPK signaling network, such as SIRT1 and PGC1α. The gene discussed is PPARGC1A; the disease is obesity disorder.